226 related articles for article (PubMed ID: 29961695)
1. Reproducibility and Utility of the 6-minute Walk Test in Systemic Sclerosis.
Pugnet G; Marjanovic Z; Deligny C; Boussardon K; Benzidia I; Puyade M; Lansiaux P; Vandecasteele E; Smith V; Farge D
J Rheumatol; 2018 Aug; 45(9):1273-1280. PubMed ID: 29961695
[TBL] [Abstract][Full Text] [Related]
2. A prospective, longitudinal study evaluating the baseline six-minute walk test as an individual reference value in systemic sclerosis patients.
Vandecasteele E; Melsens K; De Keyser F; De Pauw M; Deschepper E; Decuman S; Piette Y; Thevissen K; Brusselle G; Smith V
Clin Exp Rheumatol; 2018; 36 Suppl 113(4):95-101. PubMed ID: 30183593
[TBL] [Abstract][Full Text] [Related]
3. Six-minute walk distance as a marker for disability and complaints in patients with systemic sclerosis.
Deuschle K; Weinert K; Becker MO; Backhaus M; Huscher D; Riemekasten G
Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S53-9. PubMed ID: 21586219
[TBL] [Abstract][Full Text] [Related]
4. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
Garin MC; Highland KB; Silver RM; Strange C
J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with the 6-minute walk distance in patients with systemic sclerosis.
Sanges S; Giovannelli J; Sobanski V; Morell-Dubois S; Maillard H; Lambert M; Podevin C; Lamblin N; De Groote P; Bervar JF; Perez T; Matran R; Rémy-Jardin M; Hatron PY; Hachulla É; Launay D
Arthritis Res Ther; 2017 Dec; 19(1):279. PubMed ID: 29246248
[TBL] [Abstract][Full Text] [Related]
6. Comparison of physiological responses after incremental shuttle walking test and 6-minute walk test in patients with systemic sclerosis.
Ozcan Kahraman B; Tanriverdi A; Sezgin NH; Acar S; Birlik AM; Koken Avsar A; Akdeniz B; Ozpelit E; Savci S
Wien Klin Wochenschr; 2024 Mar; 136(5-6):169-176. PubMed ID: 36161531
[TBL] [Abstract][Full Text] [Related]
7. Relationship between left ventricular diastolic dysfunction and six minute walk test in patients with systemic sclerosis.
Akdogan A; Kaya EB; Sahin A; Okutucu S; Yakut E; Kalyoncu U; Aksoy H; Karadag O; Calguneri M; Tokgozoglu L; Kiraz S; Ertenli I
Int J Rheum Dis; 2011 Oct; 14(4):379-83. PubMed ID: 22004236
[TBL] [Abstract][Full Text] [Related]
8. Six-minute walk test in systemic sclerosis: A systematic review and meta-analysis.
Vandecasteele E; De Pauw M; De Keyser F; Decuman S; Deschepper E; Piette Y; Brusselle G; Smith V
Int J Cardiol; 2016 Jun; 212():265-73. PubMed ID: 27057932
[TBL] [Abstract][Full Text] [Related]
9. Lack of specificity of the 6-minute walk test as an outcome measure for patients with systemic sclerosis.
Schoindre Y; Meune C; Dinh-Xuan AT; Avouac J; Kahan A; Allanore Y
J Rheumatol; 2009 Jul; 36(7):1481-5. PubMed ID: 19487260
[TBL] [Abstract][Full Text] [Related]
10. The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry.
Gupta R; Baughman RP; Nathan SD; Wells AU; Kouranos V; Alhamad EH; Culver DA; Barney J; Carmona EM; Cordova FC; Huitema M; Scholand MB; Wijsenbeek M; Ganesh S; Birring SS; Price LC; Wort SJ; Shlobin OA
Respir Med; 2022 May; 196():106801. PubMed ID: 35316723
[TBL] [Abstract][Full Text] [Related]
11. Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease.
Rizzi M; Sarzi-Puttini P; Airoldi A; Antivalle M; Battellino M; Atzeni F
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S142-7. PubMed ID: 26339893
[TBL] [Abstract][Full Text] [Related]
12. Test-retest reliability, construct validity and determinants of 6-minute walk test performance in adult patients with asthma.
Meys R; Janssen SMJ; Franssen FME; Vaes AW; Stoffels AAF; van Hees HWH; van den Borst B; Klijn PH; Burtin C; van 't Hul AJ; Spruit MA
Pulmonology; 2023; 29(6):486-494. PubMed ID: 36470816
[TBL] [Abstract][Full Text] [Related]
13. Utility of the breath-holding test in patients with systemic sclerosis.
Yeo J; Kim JY; Kim MH; Park JW; Park JK; Lee EB
Rheumatology (Oxford); 2022 Oct; 61(10):4113-4118. PubMed ID: 35040945
[TBL] [Abstract][Full Text] [Related]
14. Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test.
Buch MH; Denton CP; Furst DE; Guillevin L; Rubin LJ; Wells AU; Matucci-Cerinic M; Riemekasten G; Emery P; Chadha-Boreham H; Charef P; Roux S; Black CM; Seibold JR
Ann Rheum Dis; 2007 Feb; 66(2):169-73. PubMed ID: 16868020
[TBL] [Abstract][Full Text] [Related]
15. The six-minute walk test using forehead oximetry is reliable in the assessment of scleroderma lung disease.
Wilsher M; Good N; Hopkins R; Young P; Milne D; Gibson A; Suppiah R; Ly J; Doughty R; Dalbeth N
Respirology; 2012 May; 17(4):647-52. PubMed ID: 22256786
[TBL] [Abstract][Full Text] [Related]
16. Clinical correlates and outcome associated with changes in 6-minute walking distance in patients with heart failure: findings from the BIOSTAT-CHF study.
Ferreira JP; Metra M; Anker SD; Dickstein K; Lang CC; Ng L; Samani NJ; Cleland JG; van Veldhuisen DJ; Voors AA; Zannad F
Eur J Heart Fail; 2019 Feb; 21(2):218-226. PubMed ID: 30600578
[TBL] [Abstract][Full Text] [Related]
17. Use of Six-Minute Walk Test to Measure Functional Capacity After Liver Transplantation.
VanWagner LB; Uttal S; Lapin B; Lee J; Jichlinski A; Subramanian T; Heldman M; Poole B; Bustamante E; Gunasekaran S; Tapia CS; Veerappan A; Wong SY; Levitsky J
Phys Ther; 2016 Sep; 96(9):1456-67. PubMed ID: 27055540
[TBL] [Abstract][Full Text] [Related]
18. Ventilation distribution as a contributor to the functional exercise capacity in patients with systemic sclerosis-associated interstitial lung disease without pulmonary hypertension.
Andrade FM; Oliveira AD; Lopes AJ
Braz J Med Biol Res; 2019; 52(8):e8513. PubMed ID: 31365695
[TBL] [Abstract][Full Text] [Related]
19. Echocardiographic Predictors for Worsening of Six-Minute Walk Distances in Patients With Systemic Sclerosis (Scleroderma).
Kusunose K; Yamada H; Nishio S; Hirata Y; Seno H; Saijo Y; Ise T; Tobiume T; Yamaguchi K; Yagi S; Soeki T; Wakatsuki T; Sata M
Am J Cardiol; 2017 Jul; 120(2):315-321. PubMed ID: 28532772
[TBL] [Abstract][Full Text] [Related]
20. Serum interleukin-6 in systemic sclerosis and its correlation with disease parameters and cardiopulmonary involvement.
Abdel-Magied RA; Kamel SR; Said AF; Ali HM; Abdel Gawad EA; Moussa MM
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):321-330. PubMed ID: 28079844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
